nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—prostate cancer	0.193	0.417	CbGaD
Letrozole—CYP19A1—prostate cancer	0.183	0.397	CbGaD
Letrozole—CYP3A4—prostate cancer	0.0862	0.186	CbGaD
Letrozole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0516	0.207	CbGbCtD
Letrozole—CYP3A4—Bicalutamide—prostate cancer	0.0271	0.109	CbGbCtD
Letrozole—CYP3A4—Estramustine—prostate cancer	0.0252	0.101	CbGbCtD
Letrozole—CYP3A4—Abiraterone—prostate cancer	0.0224	0.09	CbGbCtD
Letrozole—CYP3A4—Flutamide—prostate cancer	0.0224	0.09	CbGbCtD
Letrozole—CYP3A4—Cabazitaxel—prostate cancer	0.0166	0.0666	CbGbCtD
Letrozole—CYP3A4—Estrone—prostate cancer	0.0162	0.0651	CbGbCtD
Letrozole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0145	0.058	CbGbCtD
Letrozole—CYP3A4—Conjugated Estrogens—prostate cancer	0.0106	0.0426	CbGbCtD
Letrozole—CYP3A4—Mitoxantrone—prostate cancer	0.00965	0.0387	CbGbCtD
Letrozole—CYP3A4—Estradiol—prostate cancer	0.00932	0.0374	CbGbCtD
Letrozole—CYP3A4—Prednisone—prostate cancer	0.00801	0.0321	CbGbCtD
Letrozole—CYP3A4—Etoposide—prostate cancer	0.00608	0.0244	CbGbCtD
Letrozole—CYP3A4—Docetaxel—prostate cancer	0.00557	0.0223	CbGbCtD
Letrozole—CYP19A1—semen—prostate cancer	0.00436	0.408	CbGeAlD
Letrozole—CYP3A4—Doxorubicin—prostate cancer	0.00415	0.0166	CbGbCtD
Letrozole—CYP3A4—urine—prostate cancer	0.00148	0.138	CbGeAlD
Letrozole—CYP2A6—prostate gland—prostate cancer	0.00139	0.13	CbGeAlD
Letrozole—CYP2A6—seminal vesicle—prostate cancer	0.00118	0.11	CbGeAlD
Letrozole—Bifonazole—CYP17A1—prostate cancer	0.00113	0.4	CrCbGaD
Letrozole—CYP19A1—prostate gland—prostate cancer	0.00109	0.102	CbGeAlD
Letrozole—Bifonazole—CYP19A1—prostate cancer	0.000573	0.203	CrCbGaD
Letrozole—CYP19A1—testis—prostate cancer	0.000482	0.045	CbGeAlD
Letrozole—Bifonazole—CYP2E1—prostate cancer	0.000428	0.152	CrCbGaD
Letrozole—Bifonazole—CYP2C19—prostate cancer	0.000424	0.15	CrCbGaD
Letrozole—CYP3A4—renal system—prostate cancer	0.000361	0.0338	CbGeAlD
Letrozole—CYP19A1—lymph node—prostate cancer	0.000349	0.0326	CbGeAlD
Letrozole—Bifonazole—CYP3A4—prostate cancer	0.000269	0.0955	CrCbGaD
Letrozole—Haemoglobin—Epirubicin—prostate cancer	3.4e-05	0.000178	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—prostate cancer	3.4e-05	0.000178	CcSEcCtD
Letrozole—Anorexia—Docetaxel—prostate cancer	3.39e-05	0.000178	CcSEcCtD
Letrozole—Malaise—Prednisone—prostate cancer	3.39e-05	0.000178	CcSEcCtD
Letrozole—Body temperature increased—Etoposide—prostate cancer	3.39e-05	0.000178	CcSEcCtD
Letrozole—Abdominal pain—Etoposide—prostate cancer	3.39e-05	0.000178	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—prostate cancer	3.39e-05	0.000178	CcSEcCtD
Letrozole—Nervous system disorder—Capecitabine—prostate cancer	3.38e-05	0.000177	CcSEcCtD
Letrozole—Vertigo—Prednisone—prostate cancer	3.38e-05	0.000177	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—prostate cancer	3.38e-05	0.000177	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—prostate cancer	3.38e-05	0.000177	CcSEcCtD
Letrozole—Tachycardia—Capecitabine—prostate cancer	3.37e-05	0.000177	CcSEcCtD
Letrozole—Hypoaesthesia—Epirubicin—prostate cancer	3.36e-05	0.000177	CcSEcCtD
Letrozole—Skin disorder—Capecitabine—prostate cancer	3.35e-05	0.000176	CcSEcCtD
Letrozole—Sweating—Doxorubicin—prostate cancer	3.34e-05	0.000175	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—prostate cancer	3.34e-05	0.000175	CcSEcCtD
Letrozole—Hyperhidrosis—Capecitabine—prostate cancer	3.33e-05	0.000175	CcSEcCtD
Letrozole—Oedema peripheral—Epirubicin—prostate cancer	3.33e-05	0.000175	CcSEcCtD
Letrozole—Connective tissue disorder—Epirubicin—prostate cancer	3.32e-05	0.000174	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—prostate cancer	3.31e-05	0.000174	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—prostate cancer	3.3e-05	0.000173	CcSEcCtD
Letrozole—Anorexia—Capecitabine—prostate cancer	3.29e-05	0.000173	CcSEcCtD
Letrozole—Nausea—Estradiol—prostate cancer	3.28e-05	0.000172	CcSEcCtD
Letrozole—Vomiting—Mitoxantrone—prostate cancer	3.28e-05	0.000172	CcSEcCtD
Letrozole—Hypertension—Prednisone—prostate cancer	3.25e-05	0.000171	CcSEcCtD
Letrozole—Rash—Mitoxantrone—prostate cancer	3.25e-05	0.00017	CcSEcCtD
Letrozole—Dermatitis—Mitoxantrone—prostate cancer	3.25e-05	0.00017	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.24e-05	0.00017	CcSEcCtD
Letrozole—Headache—Mitoxantrone—prostate cancer	3.23e-05	0.000169	CcSEcCtD
Letrozole—Insomnia—Docetaxel—prostate cancer	3.22e-05	0.000169	CcSEcCtD
Letrozole—Arthralgia—Prednisone—prostate cancer	3.2e-05	0.000168	CcSEcCtD
Letrozole—Myalgia—Prednisone—prostate cancer	3.2e-05	0.000168	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—prostate cancer	3.2e-05	0.000168	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—prostate cancer	3.2e-05	0.000168	CcSEcCtD
Letrozole—Anxiety—Prednisone—prostate cancer	3.19e-05	0.000168	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.18e-05	0.000167	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—prostate cancer	3.17e-05	0.000167	CcSEcCtD
Letrozole—Somnolence—Docetaxel—prostate cancer	3.17e-05	0.000166	CcSEcCtD
Letrozole—Discomfort—Prednisone—prostate cancer	3.17e-05	0.000166	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—prostate cancer	3.16e-05	0.000166	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—prostate cancer	3.14e-05	0.000165	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.14e-05	0.000165	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—prostate cancer	3.14e-05	0.000165	CcSEcCtD
Letrozole—Flushing—Epirubicin—prostate cancer	3.14e-05	0.000165	CcSEcCtD
Letrozole—Dyspepsia—Docetaxel—prostate cancer	3.13e-05	0.000165	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—prostate cancer	3.13e-05	0.000164	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—prostate cancer	3.13e-05	0.000164	CcSEcCtD
Letrozole—Insomnia—Capecitabine—prostate cancer	3.12e-05	0.000164	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—prostate cancer	3.11e-05	0.000163	CcSEcCtD
Letrozole—Paraesthesia—Capecitabine—prostate cancer	3.1e-05	0.000163	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—prostate cancer	3.1e-05	0.000162	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—prostate cancer	3.09e-05	0.000162	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—prostate cancer	3.08e-05	0.000162	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Asthenia—Etoposide—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Dyspnoea—Capecitabine—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Anaphylactic shock—Prednisone—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Oedema—Prednisone—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Fatigue—Docetaxel—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—prostate cancer	3.07e-05	0.000161	CcSEcCtD
Letrozole—Nausea—Mitoxantrone—prostate cancer	3.06e-05	0.000161	CcSEcCtD
Letrozole—Infection—Prednisone—prostate cancer	3.05e-05	0.00016	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—prostate cancer	3.05e-05	0.00016	CcSEcCtD
Letrozole—Pain—Docetaxel—prostate cancer	3.05e-05	0.00016	CcSEcCtD
Letrozole—Constipation—Docetaxel—prostate cancer	3.05e-05	0.00016	CcSEcCtD
Letrozole—Dyspepsia—Capecitabine—prostate cancer	3.04e-05	0.000159	CcSEcCtD
Letrozole—Pruritus—Etoposide—prostate cancer	3.03e-05	0.000159	CcSEcCtD
Letrozole—Nervous system disorder—Prednisone—prostate cancer	3.01e-05	0.000158	CcSEcCtD
Letrozole—Tachycardia—Prednisone—prostate cancer	3e-05	0.000157	CcSEcCtD
Letrozole—Decreased appetite—Capecitabine—prostate cancer	3e-05	0.000157	CcSEcCtD
Letrozole—Alopecia—Epirubicin—prostate cancer	2.99e-05	0.000157	CcSEcCtD
Letrozole—Skin disorder—Prednisone—prostate cancer	2.98e-05	0.000157	CcSEcCtD
Letrozole—Gastrointestinal disorder—Capecitabine—prostate cancer	2.98e-05	0.000156	CcSEcCtD
Letrozole—Fatigue—Capecitabine—prostate cancer	2.97e-05	0.000156	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisone—prostate cancer	2.97e-05	0.000156	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—prostate cancer	2.96e-05	0.000155	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—prostate cancer	2.96e-05	0.000155	CcSEcCtD
Letrozole—Pain—Capecitabine—prostate cancer	2.95e-05	0.000155	CcSEcCtD
Letrozole—Constipation—Capecitabine—prostate cancer	2.95e-05	0.000155	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—prostate cancer	2.94e-05	0.000154	CcSEcCtD
Letrozole—Feeling abnormal—Docetaxel—prostate cancer	2.93e-05	0.000154	CcSEcCtD
Letrozole—Diarrhoea—Etoposide—prostate cancer	2.93e-05	0.000154	CcSEcCtD
Letrozole—Anorexia—Prednisone—prostate cancer	2.93e-05	0.000154	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—prostate cancer	2.92e-05	0.000153	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—prostate cancer	2.91e-05	0.000153	CcSEcCtD
Letrozole—Flushing—Doxorubicin—prostate cancer	2.9e-05	0.000152	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—prostate cancer	2.9e-05	0.000152	CcSEcCtD
Letrozole—Tension—Epirubicin—prostate cancer	2.89e-05	0.000152	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—prostate cancer	2.88e-05	0.000151	CcSEcCtD
Letrozole—Nervousness—Epirubicin—prostate cancer	2.86e-05	0.00015	CcSEcCtD
Letrozole—Back pain—Epirubicin—prostate cancer	2.85e-05	0.000149	CcSEcCtD
Letrozole—Feeling abnormal—Capecitabine—prostate cancer	2.84e-05	0.000149	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—prostate cancer	2.84e-05	0.000149	CcSEcCtD
Letrozole—Dizziness—Etoposide—prostate cancer	2.83e-05	0.000149	CcSEcCtD
Letrozole—Gastrointestinal pain—Capecitabine—prostate cancer	2.82e-05	0.000148	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—prostate cancer	2.82e-05	0.000148	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—prostate cancer	2.82e-05	0.000148	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—prostate cancer	2.82e-05	0.000148	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Prednisone—prostate cancer	2.8e-05	0.000147	CcSEcCtD
Letrozole—Insomnia—Prednisone—prostate cancer	2.78e-05	0.000146	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—prostate cancer	2.77e-05	0.000146	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—prostate cancer	2.76e-05	0.000145	CcSEcCtD
Letrozole—Paraesthesia—Prednisone—prostate cancer	2.76e-05	0.000145	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—prostate cancer	2.74e-05	0.000144	CcSEcCtD
Letrozole—Urticaria—Capecitabine—prostate cancer	2.74e-05	0.000144	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—prostate cancer	2.73e-05	0.000143	CcSEcCtD
Letrozole—Abdominal pain—Capecitabine—prostate cancer	2.73e-05	0.000143	CcSEcCtD
Letrozole—Body temperature increased—Capecitabine—prostate cancer	2.73e-05	0.000143	CcSEcCtD
Letrozole—Vomiting—Etoposide—prostate cancer	2.72e-05	0.000143	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—prostate cancer	2.72e-05	0.000143	CcSEcCtD
Letrozole—Dyspepsia—Prednisone—prostate cancer	2.7e-05	0.000142	CcSEcCtD
Letrozole—Rash—Etoposide—prostate cancer	2.7e-05	0.000142	CcSEcCtD
Letrozole—Dermatitis—Etoposide—prostate cancer	2.7e-05	0.000142	CcSEcCtD
Letrozole—Headache—Etoposide—prostate cancer	2.68e-05	0.000141	CcSEcCtD
Letrozole—Tension—Doxorubicin—prostate cancer	2.67e-05	0.00014	CcSEcCtD
Letrozole—Decreased appetite—Prednisone—prostate cancer	2.67e-05	0.00014	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—prostate cancer	2.67e-05	0.00014	CcSEcCtD
Letrozole—Malaise—Epirubicin—prostate cancer	2.65e-05	0.000139	CcSEcCtD
Letrozole—Fatigue—Prednisone—prostate cancer	2.65e-05	0.000139	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—prostate cancer	2.64e-05	0.000139	CcSEcCtD
Letrozole—Vertigo—Epirubicin—prostate cancer	2.64e-05	0.000139	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—prostate cancer	2.63e-05	0.000138	CcSEcCtD
Letrozole—Back pain—Doxorubicin—prostate cancer	2.63e-05	0.000138	CcSEcCtD
Letrozole—Constipation—Prednisone—prostate cancer	2.63e-05	0.000138	CcSEcCtD
Letrozole—Palpitations—Epirubicin—prostate cancer	2.6e-05	0.000137	CcSEcCtD
Letrozole—Cough—Epirubicin—prostate cancer	2.57e-05	0.000135	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—prostate cancer	2.57e-05	0.000135	CcSEcCtD
Letrozole—Asthenia—Docetaxel—prostate cancer	2.56e-05	0.000134	CcSEcCtD
Letrozole—Nausea—Etoposide—prostate cancer	2.55e-05	0.000134	CcSEcCtD
Letrozole—Hypertension—Epirubicin—prostate cancer	2.54e-05	0.000133	CcSEcCtD
Letrozole—Feeling abnormal—Prednisone—prostate cancer	2.53e-05	0.000133	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—prostate cancer	2.53e-05	0.000133	CcSEcCtD
Letrozole—Pruritus—Docetaxel—prostate cancer	2.52e-05	0.000132	CcSEcCtD
Letrozole—Gastrointestinal pain—Prednisone—prostate cancer	2.51e-05	0.000132	CcSEcCtD
Letrozole—Myalgia—Epirubicin—prostate cancer	2.51e-05	0.000132	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—prostate cancer	2.51e-05	0.000132	CcSEcCtD
Letrozole—Chest pain—Epirubicin—prostate cancer	2.51e-05	0.000132	CcSEcCtD
Letrozole—Anxiety—Epirubicin—prostate cancer	2.5e-05	0.000131	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.49e-05	0.000131	CcSEcCtD
Letrozole—Discomfort—Epirubicin—prostate cancer	2.48e-05	0.00013	CcSEcCtD
Letrozole—Asthenia—Capecitabine—prostate cancer	2.47e-05	0.00013	CcSEcCtD
Letrozole—Malaise—Doxorubicin—prostate cancer	2.46e-05	0.000129	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—prostate cancer	2.45e-05	0.000129	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—prostate cancer	2.45e-05	0.000128	CcSEcCtD
Letrozole—Urticaria—Prednisone—prostate cancer	2.44e-05	0.000128	CcSEcCtD
Letrozole—Pruritus—Capecitabine—prostate cancer	2.44e-05	0.000128	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—prostate cancer	2.44e-05	0.000128	CcSEcCtD
Letrozole—Diarrhoea—Docetaxel—prostate cancer	2.44e-05	0.000128	CcSEcCtD
Letrozole—Body temperature increased—Prednisone—prostate cancer	2.43e-05	0.000127	CcSEcCtD
Letrozole—Abdominal pain—Prednisone—prostate cancer	2.43e-05	0.000127	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—prostate cancer	2.41e-05	0.000126	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—prostate cancer	2.4e-05	0.000126	CcSEcCtD
Letrozole—Oedema—Epirubicin—prostate cancer	2.4e-05	0.000126	CcSEcCtD
Letrozole—Infection—Epirubicin—prostate cancer	2.39e-05	0.000125	CcSEcCtD
Letrozole—Cough—Doxorubicin—prostate cancer	2.38e-05	0.000125	CcSEcCtD
Letrozole—Diarrhoea—Capecitabine—prostate cancer	2.36e-05	0.000124	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—prostate cancer	2.36e-05	0.000124	CcSEcCtD
Letrozole—Dizziness—Docetaxel—prostate cancer	2.35e-05	0.000124	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—prostate cancer	2.35e-05	0.000123	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—prostate cancer	2.34e-05	0.000123	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—prostate cancer	2.33e-05	0.000122	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—prostate cancer	2.32e-05	0.000122	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—prostate cancer	2.32e-05	0.000122	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—prostate cancer	2.32e-05	0.000122	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—prostate cancer	2.32e-05	0.000122	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—prostate cancer	2.31e-05	0.000121	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.3e-05	0.000121	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—prostate cancer	2.29e-05	0.00012	CcSEcCtD
Letrozole—Anorexia—Epirubicin—prostate cancer	2.29e-05	0.00012	CcSEcCtD
Letrozole—Dizziness—Capecitabine—prostate cancer	2.28e-05	0.00012	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—prostate cancer	2.27e-05	0.000119	CcSEcCtD
Letrozole—Vomiting—Docetaxel—prostate cancer	2.26e-05	0.000119	CcSEcCtD
Letrozole—Rash—Docetaxel—prostate cancer	2.25e-05	0.000118	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—prostate cancer	2.24e-05	0.000118	CcSEcCtD
Letrozole—Headache—Docetaxel—prostate cancer	2.23e-05	0.000117	CcSEcCtD
Letrozole—Oedema—Doxorubicin—prostate cancer	2.22e-05	0.000117	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—prostate cancer	2.22e-05	0.000117	CcSEcCtD
Letrozole—Infection—Doxorubicin—prostate cancer	2.21e-05	0.000116	CcSEcCtD
Letrozole—Asthenia—Prednisone—prostate cancer	2.2e-05	0.000116	CcSEcCtD
Letrozole—Vomiting—Capecitabine—prostate cancer	2.19e-05	0.000115	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.19e-05	0.000115	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—prostate cancer	2.18e-05	0.000114	CcSEcCtD
Letrozole—Rash—Capecitabine—prostate cancer	2.17e-05	0.000114	CcSEcCtD
Letrozole—Pruritus—Prednisone—prostate cancer	2.17e-05	0.000114	CcSEcCtD
Letrozole—Insomnia—Epirubicin—prostate cancer	2.17e-05	0.000114	CcSEcCtD
Letrozole—Dermatitis—Capecitabine—prostate cancer	2.17e-05	0.000114	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—prostate cancer	2.17e-05	0.000114	CcSEcCtD
Letrozole—Headache—Capecitabine—prostate cancer	2.16e-05	0.000113	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—prostate cancer	2.16e-05	0.000113	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—prostate cancer	2.16e-05	0.000113	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—prostate cancer	2.15e-05	0.000113	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—prostate cancer	2.14e-05	0.000112	CcSEcCtD
Letrozole—Somnolence—Epirubicin—prostate cancer	2.14e-05	0.000112	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—prostate cancer	2.12e-05	0.000111	CcSEcCtD
Letrozole—Nausea—Docetaxel—prostate cancer	2.12e-05	0.000111	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—prostate cancer	2.11e-05	0.000111	CcSEcCtD
Letrozole—Diarrhoea—Prednisone—prostate cancer	2.1e-05	0.00011	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—prostate cancer	2.09e-05	0.00011	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—prostate cancer	2.07e-05	0.000109	CcSEcCtD
Letrozole—Fatigue—Epirubicin—prostate cancer	2.07e-05	0.000109	CcSEcCtD
Letrozole—Pain—Epirubicin—prostate cancer	2.05e-05	0.000108	CcSEcCtD
Letrozole—Constipation—Epirubicin—prostate cancer	2.05e-05	0.000108	CcSEcCtD
Letrozole—Nausea—Capecitabine—prostate cancer	2.05e-05	0.000108	CcSEcCtD
Letrozole—Dizziness—Prednisone—prostate cancer	2.03e-05	0.000107	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.02e-05	0.000106	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—prostate cancer	2.01e-05	0.000106	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—prostate cancer	2e-05	0.000105	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—prostate cancer	1.98e-05	0.000104	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—prostate cancer	1.98e-05	0.000104	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—prostate cancer	1.98e-05	0.000104	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—prostate cancer	1.96e-05	0.000103	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—prostate cancer	1.96e-05	0.000103	CcSEcCtD
Letrozole—Vomiting—Prednisone—prostate cancer	1.95e-05	0.000102	CcSEcCtD
Letrozole—Rash—Prednisone—prostate cancer	1.94e-05	0.000102	CcSEcCtD
Letrozole—Dermatitis—Prednisone—prostate cancer	1.93e-05	0.000102	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—prostate cancer	1.93e-05	0.000101	CcSEcCtD
Letrozole—Headache—Prednisone—prostate cancer	1.92e-05	0.000101	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.92e-05	0.000101	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—prostate cancer	1.92e-05	0.000101	CcSEcCtD
Letrozole—Urticaria—Epirubicin—prostate cancer	1.91e-05	0.0001	CcSEcCtD
Letrozole—Constipation—Doxorubicin—prostate cancer	1.9e-05	9.98e-05	CcSEcCtD
Letrozole—Pain—Doxorubicin—prostate cancer	1.9e-05	9.98e-05	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—prostate cancer	1.9e-05	9.97e-05	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—prostate cancer	1.9e-05	9.97e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ABCG5—prostate cancer	1.86e-05	0.000221	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SULT1A1—prostate cancer	1.86e-05	0.000221	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GGT1—prostate cancer	1.84e-05	0.000218	CbGpPWpGaD
Letrozole—Feeling abnormal—Doxorubicin—prostate cancer	1.83e-05	9.61e-05	CcSEcCtD
Letrozole—Nausea—Prednisone—prostate cancer	1.82e-05	9.58e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GSTA1—prostate cancer	1.82e-05	0.000216	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Doxorubicin—prostate cancer	1.82e-05	9.54e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—ARG2—prostate cancer	1.81e-05	0.000215	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UMPS—prostate cancer	1.81e-05	0.000215	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PHGDH—prostate cancer	1.81e-05	0.000215	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—NCOA1—prostate cancer	1.81e-05	0.000215	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTO1—prostate cancer	1.8e-05	0.000214	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NAT2—prostate cancer	1.8e-05	0.000214	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD3B2—prostate cancer	1.8e-05	0.000214	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	1.78e-05	0.000212	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LDHB—prostate cancer	1.78e-05	0.000211	CbGpPWpGaD
Letrozole—Urticaria—Doxorubicin—prostate cancer	1.77e-05	9.27e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	1.76e-05	0.000209	CbGpPWpGaD
Letrozole—Abdominal pain—Doxorubicin—prostate cancer	1.76e-05	9.22e-05	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—prostate cancer	1.76e-05	9.22e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CYP3A5—prostate cancer	1.74e-05	0.000207	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.73e-05	0.000205	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLCB2—prostate cancer	1.72e-05	0.000205	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LRP2—prostate cancer	1.72e-05	0.000205	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2C18—prostate cancer	1.72e-05	0.000205	CbGpPWpGaD
Letrozole—Asthenia—Epirubicin—prostate cancer	1.72e-05	9.05e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—RXRA—prostate cancer	1.72e-05	0.000204	CbGpPWpGaD
Letrozole—Pruritus—Epirubicin—prostate cancer	1.7e-05	8.92e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—P4HB—prostate cancer	1.69e-05	0.000201	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PDHA1—prostate cancer	1.68e-05	0.0002	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA3—prostate cancer	1.68e-05	0.0002	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UCP3—prostate cancer	1.68e-05	0.0002	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TCN2—prostate cancer	1.68e-05	0.0002	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—COMT—prostate cancer	1.66e-05	0.000197	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTP1—prostate cancer	1.65e-05	0.000196	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC22A1—prostate cancer	1.65e-05	0.000195	CbGpPWpGaD
Letrozole—Diarrhoea—Epirubicin—prostate cancer	1.64e-05	8.63e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	1.63e-05	0.000194	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	1.63e-05	0.000194	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	1.63e-05	0.000193	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.63e-05	0.000193	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC22A3—prostate cancer	1.61e-05	0.000191	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD3B1—prostate cancer	1.61e-05	0.000191	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SULT2A1—prostate cancer	1.6e-05	0.00019	CbGpPWpGaD
Letrozole—Asthenia—Doxorubicin—prostate cancer	1.59e-05	8.37e-05	CcSEcCtD
Letrozole—Dizziness—Epirubicin—prostate cancer	1.59e-05	8.34e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—MED12—prostate cancer	1.58e-05	0.000187	CbGpPWpGaD
Letrozole—Pruritus—Doxorubicin—prostate cancer	1.57e-05	8.25e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GNG5—prostate cancer	1.57e-05	0.000186	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TBXAS1—prostate cancer	1.54e-05	0.000183	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA4—prostate cancer	1.54e-05	0.000183	CbGpPWpGaD
Letrozole—Vomiting—Epirubicin—prostate cancer	1.53e-05	8.02e-05	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—prostate cancer	1.52e-05	7.98e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.52e-05	0.00018	CbGpPWpGaD
Letrozole—Rash—Epirubicin—prostate cancer	1.51e-05	7.95e-05	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—prostate cancer	1.51e-05	7.94e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—NCOA3—prostate cancer	1.51e-05	0.000179	CbGpPWpGaD
Letrozole—Headache—Epirubicin—prostate cancer	1.5e-05	7.9e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—GSTA2—prostate cancer	1.5e-05	0.000178	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.5e-05	0.000177	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG5—prostate cancer	1.48e-05	0.000176	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SULT1A1—prostate cancer	1.48e-05	0.000176	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.48e-05	0.000176	CbGpPWpGaD
Letrozole—Dizziness—Doxorubicin—prostate cancer	1.47e-05	7.71e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—GSTA1—prostate cancer	1.45e-05	0.000172	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HPGDS—prostate cancer	1.44e-05	0.000171	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.44e-05	0.000171	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NAT2—prostate cancer	1.43e-05	0.00017	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTO1—prostate cancer	1.43e-05	0.00017	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD3B2—prostate cancer	1.43e-05	0.00017	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2C19—prostate cancer	1.43e-05	0.00017	CbGpPWpGaD
Letrozole—Nausea—Epirubicin—prostate cancer	1.43e-05	7.49e-05	CcSEcCtD
Letrozole—CYP3A4—Metabolism—HAO1—prostate cancer	1.42e-05	0.000168	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.42e-05	0.000168	CbGpPWpGaD
Letrozole—Vomiting—Doxorubicin—prostate cancer	1.41e-05	7.42e-05	CcSEcCtD
Letrozole—Rash—Doxorubicin—prostate cancer	1.4e-05	7.36e-05	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—prostate cancer	1.4e-05	7.35e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GSTT1—prostate cancer	1.39e-05	0.000166	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ACHE—prostate cancer	1.39e-05	0.000166	CbGpPWpGaD
Letrozole—Headache—Doxorubicin—prostate cancer	1.39e-05	7.31e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CYP2A6—prostate cancer	1.38e-05	0.000164	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.37e-05	0.000163	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLCB2—prostate cancer	1.37e-05	0.000163	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2C18—prostate cancer	1.37e-05	0.000163	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LRP2—prostate cancer	1.37e-05	0.000163	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—P4HB—prostate cancer	1.35e-05	0.00016	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKR1C3—prostate cancer	1.34e-05	0.000159	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PRKACB—prostate cancer	1.33e-05	0.000158	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP17A1—prostate cancer	1.32e-05	0.000157	CbGpPWpGaD
Letrozole—Nausea—Doxorubicin—prostate cancer	1.32e-05	6.93e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—SLC22A1—prostate cancer	1.31e-05	0.000155	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.3e-05	0.000155	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SULT2A1—prostate cancer	1.28e-05	0.000151	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOA2—prostate cancer	1.26e-05	0.000149	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MED12—prostate cancer	1.26e-05	0.000149	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GNG5—prostate cancer	1.25e-05	0.000148	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC5A5—prostate cancer	1.2e-05	0.000142	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA3—prostate cancer	1.2e-05	0.000142	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2E1—prostate cancer	1.17e-05	0.000139	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NQO1—prostate cancer	1.16e-05	0.000138	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PSAT1—prostate cancer	1.16e-05	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CBR1—prostate cancer	1.16e-05	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CSAD—prostate cancer	1.16e-05	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TST—prostate cancer	1.16e-05	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GRHL1—prostate cancer	1.16e-05	0.000137	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADI1—prostate cancer	1.16e-05	0.000137	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HPGDS—prostate cancer	1.14e-05	0.000136	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TH—prostate cancer	1.14e-05	0.000136	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2C19—prostate cancer	1.14e-05	0.000135	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.14e-05	0.000135	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP3A4—prostate cancer	1.13e-05	0.000134	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.12e-05	0.000133	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1B1—prostate cancer	1.11e-05	0.000132	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTT1—prostate cancer	1.11e-05	0.000132	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ACHE—prostate cancer	1.11e-05	0.000132	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GGT1—prostate cancer	1.08e-05	0.000128	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.08e-05	0.000128	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CKMT2—prostate cancer	1.08e-05	0.000128	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.08e-05	0.000128	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GRHPR—prostate cancer	1.08e-05	0.000128	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKR1C3—prostate cancer	1.07e-05	0.000127	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PRKACB—prostate cancer	1.06e-05	0.000126	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOA1—prostate cancer	1.06e-05	0.000126	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP17A1—prostate cancer	1.05e-05	0.000125	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM3—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—RFK—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AOX1—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PGAM2—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAGLU—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—RXRA—prostate cancer	1.01e-05	0.00012	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA2—prostate cancer	1e-05	0.000119	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.81e-06	0.000116	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—COMT—prostate cancer	9.71e-06	0.000115	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTP1—prostate cancer	9.67e-06	0.000115	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AMACR—prostate cancer	9.58e-06	0.000114	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP3A43—prostate cancer	9.58e-06	0.000114	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAT1—prostate cancer	9.58e-06	0.000114	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SRD5A2—prostate cancer	9.58e-06	0.000114	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—DEGS1—prostate cancer	9.58e-06	0.000114	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC5A5—prostate cancer	9.55e-06	0.000113	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ITPR1—prostate cancer	9.51e-06	0.000113	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.35e-06	0.000111	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2E1—prostate cancer	9.33e-06	0.000111	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NQO1—prostate cancer	9.23e-06	0.00011	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.14e-06	0.000108	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TH—prostate cancer	9.09e-06	0.000108	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP3A4—prostate cancer	9e-06	0.000107	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TYMS—prostate cancer	8.99e-06	0.000107	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—prostate cancer	8.89e-06	0.000105	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1B1—prostate cancer	8.85e-06	0.000105	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LPL—prostate cancer	8.72e-06	0.000104	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GGT1—prostate cancer	8.57e-06	0.000102	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA1—prostate cancer	8.44e-06	0.0001	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A1—prostate cancer	8.42e-06	0.0001	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ERCC2—prostate cancer	8.35e-06	9.91e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP19A1—prostate cancer	8.32e-06	9.87e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HPGD—prostate cancer	8.15e-06	9.67e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.15e-06	9.67e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—RXRA—prostate cancer	8.03e-06	9.53e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—prostate cancer	7.85e-06	9.32e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—COMT—prostate cancer	7.73e-06	9.18e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARA—prostate cancer	7.7e-06	9.14e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTP1—prostate cancer	7.7e-06	9.13e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TNFRSF21—prostate cancer	7.66e-06	9.09e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ITPR1—prostate cancer	7.57e-06	8.99e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTAP—prostate cancer	7.45e-06	8.84e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.45e-06	8.84e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.26e-06	8.62e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.26e-06	8.62e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAV1—prostate cancer	7.24e-06	8.6e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TYMS—prostate cancer	7.15e-06	8.49e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—prostate cancer	7.07e-06	8.39e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LPL—prostate cancer	6.94e-06	8.24e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ACSL4—prostate cancer	6.93e-06	8.22e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.93e-06	8.22e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.92e-06	8.21e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A1—prostate cancer	6.7e-06	7.96e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ERCC2—prostate cancer	6.65e-06	7.89e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UMPS—prostate cancer	6.64e-06	7.88e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PHGDH—prostate cancer	6.64e-06	7.88e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ARG2—prostate cancer	6.64e-06	7.88e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—prostate cancer	6.6e-06	7.83e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LDHB—prostate cancer	6.51e-06	7.73e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.39e-06	7.59e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—prostate cancer	6.25e-06	7.42e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—INS—prostate cancer	6.25e-06	7.41e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PDHA1—prostate cancer	6.17e-06	7.33e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA3—prostate cancer	6.17e-06	7.33e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TCN2—prostate cancer	6.17e-06	7.33e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UCP3—prostate cancer	6.17e-06	7.33e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARA—prostate cancer	6.13e-06	7.28e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CREBBP—prostate cancer	6.12e-06	7.26e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.89e-06	6.99e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.89e-06	6.99e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CD—prostate cancer	5.8e-06	6.88e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAV1—prostate cancer	5.77e-06	6.84e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.65e-06	6.7e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA4—prostate cancer	5.65e-06	6.7e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA2—prostate cancer	5.5e-06	6.53e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NOS3—prostate cancer	5.48e-06	6.5e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.44e-06	6.45e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG5—prostate cancer	5.44e-06	6.45e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA1—prostate cancer	5.31e-06	6.3e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—prostate cancer	5.25e-06	6.23e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTO1—prostate cancer	5.25e-06	6.23e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAT2—prostate cancer	5.25e-06	6.23e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.25e-06	6.23e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CB—prostate cancer	5.06e-06	6e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLCB2—prostate cancer	5.03e-06	5.97e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.03e-06	5.97e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LRP2—prostate cancer	5.03e-06	5.97e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—prostate cancer	5.01e-06	5.94e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—INS—prostate cancer	4.97e-06	5.9e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—P4HB—prostate cancer	4.94e-06	5.86e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CREBBP—prostate cancer	4.87e-06	5.78e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.8e-06	5.7e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.68e-06	5.55e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CD—prostate cancer	4.62e-06	5.48e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MED12—prostate cancer	4.6e-06	5.46e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GNG5—prostate cancer	4.57e-06	5.42e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA3—prostate cancer	4.4e-06	5.22e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTEN—prostate cancer	4.37e-06	5.18e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NOS3—prostate cancer	4.36e-06	5.17e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HPGDS—prostate cancer	4.2e-06	4.98e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.17e-06	4.95e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—EP300—prostate cancer	4.17e-06	4.94e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ACHE—prostate cancer	4.07e-06	4.83e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTT1—prostate cancer	4.07e-06	4.83e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.02e-06	4.78e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CB—prostate cancer	4.02e-06	4.78e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—prostate cancer	3.99e-06	4.73e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.91e-06	4.65e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PRKACB—prostate cancer	3.89e-06	4.62e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.85e-06	4.57e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA2—prostate cancer	3.67e-06	4.36e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.5e-06	4.16e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTEN—prostate cancer	3.48e-06	4.13e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.42e-06	4.06e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NQO1—prostate cancer	3.38e-06	4.02e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TH—prostate cancer	3.33e-06	3.96e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—EP300—prostate cancer	3.32e-06	3.94e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.24e-06	3.85e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GGT1—prostate cancer	3.14e-06	3.73e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA1—prostate cancer	3.09e-06	3.67e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—prostate cancer	3.08e-06	3.66e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.05e-06	3.62e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—RXRA—prostate cancer	2.94e-06	3.49e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—COMT—prostate cancer	2.83e-06	3.36e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTP1—prostate cancer	2.82e-06	3.35e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ITPR1—prostate cancer	2.78e-06	3.3e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TYMS—prostate cancer	2.62e-06	3.11e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—prostate cancer	2.59e-06	3.08e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LPL—prostate cancer	2.55e-06	3.02e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—prostate cancer	2.52e-06	2.99e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.46e-06	2.92e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—prostate cancer	2.45e-06	2.91e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ERCC2—prostate cancer	2.44e-06	2.89e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—prostate cancer	2.29e-06	2.72e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARA—prostate cancer	2.25e-06	2.67e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAV1—prostate cancer	2.11e-06	2.51e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—prostate cancer	2e-06	2.38e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.93e-06	2.29e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—INS—prostate cancer	1.82e-06	2.16e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CREBBP—prostate cancer	1.79e-06	2.12e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.69e-06	2.01e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NOS3—prostate cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.48e-06	1.75e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—prostate cancer	1.46e-06	1.73e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTEN—prostate cancer	1.27e-06	1.51e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—EP300—prostate cancer	1.22e-06	1.44e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.99e-07	1.07e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—prostate cancer	7.35e-07	8.72e-06	CbGpPWpGaD
